Aura Biosciences AURA
NASDAQ AURA
$6.09 +0.05 (+0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aura Biosciences (AURA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Aura Biosciences' Return on Capital Employed [ROCE] came in at -61.82% for Q2 2026, up 4.03 percentage points from -65.85% a year earlier and up 24.86 percentage points from the prior quarter.

Analysis

Aura Biosciences (AURA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Aura Biosciences' Return on Capital Employed [ROCE] was -71.58%, down 24.43 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last three years, with a four-year change of -29.47 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -47.14% in FY2024 (-9.73 pp), -37.42% in FY2023 (-4.20 pp), -33.22% in FY2022 (+8.89 pp) and -42.11% in FY2021.
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • Year-over-year, Return on Capital Employed [ROCE] increased in 1 of the last eight quarters, with an average year-over-year change of -14.63 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 4.03 percentage points), and the weakest in Q1 2025 (a drop of 28.26 percentage points).
  • Business Quant data shows AURA's Return on Capital Employed [ROCE] at -86.68% (Q1 2026), -69.91% (Q4 2025) and -63.55% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Aura Biosciences 630.19 Mn 370.50 Mn - -61.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -61.82%
Mar 31, 2026 -86.68%
Dec 31, 2025 -69.91%
Sep 30, 2025 -63.55%
Jun 30, 2025 -65.85%
Mar 31, 2025 -65.59%
Dec 31, 2024 -53.69%
Sep 30, 2024 -47.23%
Jun 30, 2024 -41.81%
Mar 31, 2024 -37.33%
Dec 31, 2023 -41.45%
Sep 30, 2023 -44.38%
Jun 30, 2023 -38.53%
Mar 31, 2023 -32.35%
Dec 31, 2022 -34.84%
Sep 30, 2022 -42.06%
Jun 30, 2022 -34.95%
Mar 31, 2022 -28.43%
Dec 31, 2021 -29.87%
API Access

Aura Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AURA&period=max&api_key=YOUR_API_KEY